Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tamoxifen to Treat Barrett's Metaplasia

NCT02089386 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02089386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02089386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tamoxifen to Treat Barrett's Metaplasia
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Terminated
Start date
July 9, 2014
Completion date
June 21, 2016
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett metaplasia